ReviewClinical nephrology2010
The impact of disadvantage on the development and progression of diabetic kidney disease.
Review in Clinical nephrology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 14 citations in OpenAlex.
- Factors associated with chronic kidney disease in patients with diabetes in French Guiana.Frontiers in clinical diabetes and healthcare · 2023Article
- The impact of race and socioeconomic factors on paediatric diabetes.EClinicalMedicine · 2021Review
- Prevalence of Tuberculosis Disease Among Adult US-Bound Refugees with Chronic Kidney Disease.Journal of immigrant and minority health · 2019Article
- The Global Epidemiology of Diabetes and Kidney Disease.Advances in chronic kidney disease · 2018Review
- Diabetic kidney disease.Nature reviews. Disease primers · 2015Review
- Diabetic nephropathy in Africa: A systematic review.World journal of diabetes · 2015Article
- Racial disparities in diabetes mortality in the 50 most populous US cities.Journal of urban health : bulletin of the New York Academy of Medicine · 2014Article
- Impact of the hypoxia-inducible factor-1 α (HIF1A) Pro582Ser polymorphism on diabetes nephropathy.Diabetes care · 2013Article
- Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy.Frontiers in endocrinology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundDisadvantaged people include those experiencing economic, social or educational deprivation and, in some cases, those undergoing rapid transition from subsistence to industrial economies. Disadvantaged people worldwide are affected disproportionately by the global epidemic of diabetes. They are also at increased risk of kidney disease attributable to diabetes, and for many, the cost of managing their kidney disease far exceeds their available resources.
methodsWe review factors associated with disadvantage that may increase the risk of diabetic kidney disease, and the barriers to care that hinder attempts to provide an adequate therapeutic response. RESULTS AND
conclusionsA rapidly rising prevalence and magnitude of obesity among children and adults, increasing frequency of intrauterine exposure to diabetes, and inadequate access to healthcare are responsible, in part, for a surge in the frequency of diabetes and, in turn, diabetic kidney disease among disadvantaged people. These factors may also predispose to an earlier onset of diabetes and kidney disease, thereby perpetuating the disadvantage by reducing the earning potential of those affected through illness and disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.